Flex Pharma (FLKS) Tops Q1 EPS by 3c

Flex Pharma (NASDAQ: FLKS) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $179 thousand versus the consensus estimate of $280 thousand.

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?